Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus.

SA increases the odds of flare at remission but not at CID. Suboptimal dosing of hydroxychloroquine should be avoided, especially in children with SA in remission to lower the risk of flares.